ExpiresDecember 1, 2021
Fee$149 - $199
CME Provider: American Society of Addiction Medicine
Description of CME Course
This activity is based on gaps with education of healthcare providers seeing/treating patients with opioid use disorder, as well as DATA2000 legislation requiring provider obtain a waiver to prescribe buprenorphine in an office setting.
ABMS Member Board Approvals by Type
ABMS MOC Part II CME Activity
Physical Medicine and Rehabilitation
Psychiatry and Neurology
NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
1. Identify, assess and diagnose patients with opioid use disorder while considering severity, chronicity, individual characteristics, and psychiatric and medical comorbidities.
2. Develop an individualized, patient-centered treatment plan including negotiating treatment goals by evaluating appropriate medication- and psychosocial-based treatment options.
3. Monitor progress and modify treatment plan based on patient needs and progress toward treatment goals.
4. Implement best practices for office systems including team-based care to support treatment with medications for opioid use disorder.
5. Examine misconceptions, stigma, and complexities (bioethical, social, clinical, public health) associated with opioid use disorder and the use of medications to treat opioid use disorder.
Addiction, Addiction Medicine, Primary Care
Medical Knowledge, Professionalism, Systems-based Practice
CME Credit Type
AAFP Prescribed Credit, AMA PRA Category 1 Credit
Physician Well-being activity
Efficiencies in Medical Practice
Academic Medicine, Inpatient, Outpatient, Rural, Urban, VA/Military